WBC
Total immune-cell count - chronic low-grade elevation correlates with inflammation, mortality, and metabolic disease.
How WBC ranges relate
The standard lab range vs the optimization-focused target. Illustrative trajectory shows what a 12-week improvement pattern looks like — not real user data.
What WBC Measures
WBC is the total count of circulating immune cells - neutrophils, lymphocytes, monocytes, eosinophils, basophils. Acute infection drives dramatic elevations; chronic stress, smoking, obesity, and underlying inflammatory conditions drive smaller but persistent elevations.
The shift across the normal range (from 5 to 8, for example) within "normal" carries meaningful prognostic information in long-term cohorts - lower end correlates with longer lifespan in several large datasets.
What Affects This Biomarker
WBC is influenced by: acute infection (large rise), chronic inflammation (modest persistent rise), smoking (notable rise that reverses), cortisol/steroid use (raises it through demargination), exercise (transient rise), and bone marrow status. Very low values warrant workup.
In the Context of Peptide Protocols
Review CBC annually as baseline. Unexpected chronic elevations (persistently >8) may reflect subclinical inflammation worth investigating. Many optimization users track this alongside hs-CRP.
Peptides That Commonly Move WBC
Upload any lab PDF and MyProtocolStack maps your values to WBC and 40+ other biomarkers. StackAI interprets the trend in context of your protocol.
Start tracking →Informational only - not medical advice. Reference ranges vary by lab and individual context. Work with a licensed provider to interpret your specific results.